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Abstract: Nicotine, a potent parasympathomimetic alkaloid with stimulant eff ects, is contributing to 
addictive properties of tobacco smoking and is though used in the smoking cessation therapy. Hydro-
gen sulfi de (H2S) is involved in physiology and pathophysiology of various systems in mammals. Th e 
interactions between nicotine and H2S are not fully recognized. Th e aim of the study is to assess the 
infl uence of nicotine on the H2S tissue concentrations in diff erent mouse organs. Adult CBA male mice 
were administered intraperitoneally 1.5 mg/kg b.w. per day of nicotine (group D1, n = 10) or 3 mg/
kg b.w. per day of nicotine (group D2, n = 10). Th e control group (n = 10) received physiological sa-
line. Th e measurements of the free and acid-labile H2S tissue concentrations were performed with the 
Siegel spectrophotometric modifi ed method. Th ere was a  signifi cant increase in H2S concentrations 
in both nicotine doses groups in the kidney (D1 by 54.2%, D2 by 40.0%). In the heart the higher nic-
otine dose caused a marked decrease in H2S tissue level (by 65.4%), while the lower dose did not af-
fect H2S content. Nicotine administration had no eff ect on H2S concentrations in the brain and liver. 
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In conclusion, nicotine aff ects H2S tissue concentrations in kidney and heart but not in the liver and 
brain tissues. 
Key words: nicotine, hydrogen sulfi de, brain, heart, kidney, liver, mouse.
Introduction
Nicotine is a potent parasympathomimetic alkaloid found in the nightshade family of 
plants including Nicotiana tabacum. It serves as an agonist towards diff erent subtypes 
of fi ve-subunit nicotinic acetylocholine receptors (nAChR), members of the ‘Cys-loop’ 
superfamily, whereas in specifi c subtypes of them — nAChRα9 and nAChRα10 it 
acts as an antagonist [1]. Nicotinic receptors play diverse and oft en critical functions 
throughout the central and peripheral nervous systems and have emerging roles in 
non-neuronal systems. Th e nAChRs have been identifi ed i.a. in bronchial epithelial 
cells, endothelial cells, vascular smooth muscle cells, mesangial cells, infl ammatory 
cells and keratinocytes [2, 3].
Nicotine has stimulant effects and is contributing to addictive properties of 
tobacco use and is therefore widely applied in the smoking cessation therapy [4]. 
Cigarette smoking has great socioeconomic repercussions — it is the leading cause of 
preventable mortality and disability worldwide — the habit aff ects one billion people 
throughout the world and causes near six million deaths each year [5]. Furthermore, 
nicotine administration poses several health hazards. The alkaloid has been 
demonstrated to aff ect cell proliferation, oxidative stress, apoptosis, decrease immune 
response and contribute to DNA damage what altogether leads in eff ect to increased 
risk of cardiovascular events, respiratory, reproductive and gastrointestinal disorders 
and cancer development [6, 7]. 
Th e studies of the recent decade have uncovered the biological signifi cance of 
hydrogen sulfi de (H2S) and subsequently changed its perception from an odorous 
by-product of putrescence processes to a  crucial co-modulator in physiology and 
pathophysiology of various systems in mammals [8]. H2S is formed in a  series of 
enzymatic reactions in which the substrates are sulfur-containing amino acids such 
as L-cysteine, L-homocysteine and D-cysteine. Th e key enzymes are cystathionine 
γ-lyase (CSE), cystathionine β-synthase (CBS), cysteine aminotransferase (CAT), 
3-mercaptopyruvate sulfur transferase (3-MST) and D-amino acid oxidase (DAO). 
H2S is also a  product in a  few other enzymatic reactions of the complex sulfur 
metabolism and in non-enzymatic reactions [9]. It is recognized that H2S acts mainly 
in a  paracrine manner but it is also transported to other tissues as a  component of 
the serum and inside erythrocytes. Th is gaseous messenger exerts a  broad array of 
biological actions. No specifi c receptor to H2S has been identifi ed. Th e molecular 
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targets of H2S are varied and comprise many proteins which participate in the 
regulation of crucial physiological processes. Th e most important mechanisms of 
action involve sulfh ydration of proteins and their redox regulation, modifi cation of 
prosthetic groups, interaction with nitric oxide (NO) and carbon monoxide (CO), 
participation in S-nitrozylation of proteins, interaction with reactive oxygen species 
(ROS) and electrophile lipid derivatives [10]. The biological effects of H2S cover 
changes in the activity of ion channels, N-methyl-D-aspartate (NMDA) receptors, 
various signaling proteins, transcription factors, enzymes, structural and transport 
proteins [11].
Data on the share of H2S in the development of complications of smoking are 
scarce. H2S alleviated airway reactivity induced by acetylocholine (ACh) or potassium 
chloride and reduced inflammatory cytokines interleukin 8 and tumor necrosis 
factor α (TNF-α) in a  rat model of chronic exposure to cigarette smoke [12]. Th e 
mediator ameliorated tobacco smoke-induced oxidative stress and emphysema in 
mice and pulmonary fi brosis in smoking rats via attenuation of oxidative stress and 
infl ammation [13, 14]. H2S improved left  ventricular function in smoking rats via 
regulation of apoptosis and autophagy [15]. Additionally, mounting evidence shows 
pivotal role of H2S in the function of the brain and changes of H2S generation in cases 
of exposure to diff erent compounds and drugs [9, 16, 17]. 
Th e interactions between nicotine, cigarette toxins and H2S are not fully recognized 
[18]. Th e indication of the infl uence of nicotine on sulfur metabolism might help 
to evolve more effi  cient smoking cessation and addiction therapies. Moreover, the 
elaboration of compounds correcting sulfur biology disturbances observed in various 
smoking-related diseases might hamper their progression and improve mortality and 
morbidity outcomes. 
Th e aim of the study is to assess the infl uence of nicotine on the endogenous H2S 
tissue concentrations in diff erent mouse organs.
Material and methods
Animals 
Th e study has been approved by the II Local Ethics Committee for Animal 
Experimentation in Krakow at the Polish Academy of Sciences (Krakow, Poland) with 
the permission no. 24/2016 issued on 22nd March 2016.
Th irty CBA male mice (15-week-old individuals) of approximate 20 g weight were 
involved in the study. Th e animals were housed under standard laboratory conditions 
and had free access to water and food. Th ey were kept at temperature of 22–24°C 
with a light/dark cycle of 12 h (8 am — 8 pm and 8 pm — 8 am, respectively). 
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Study design
With the median lethal dose estimated at around 4 kg per kg body weight in mice, 
the study protocol comprised intraperitoneal injections of nicotine dissolved in 
a  saline solution in doses of 1.5 mg per kg of body weight daily (group D1, n = 10) 
or 3 mg per kg of body weight daily (group D2, n = 10) for 5 consecutive days at the 
same time of the day (9:00 am) — each administration of 0.2 ml [19]. Th e control 
group (n = 10) received intraperitoneally physiological saline in portions of the same 
volume. Th e individuals were randomly assigned to each group. Th e animals tolerated 
the applied doses of nicotine well and remained in good condition till the end of the 
experiment. Measurements of the free and acid-labile tissue H2S concentrations were 
performed by the use of the modifi ed method of Siegel [20, 21]. A standard curve was 
prepared with sodium sulfi de solutions simultaneously analyzed by the iodometric 
titration.
Tissue sample preparation
An hour aft er the last nicotine solution or physiological saline injections the animals 
were killed by cervical dislocation. Brain, heart, kidney and liver tissues of each animal 
were quickly removed, homogenized with 0.01 M sodium hydroxide (NaOH) and 
frozen. Each tissue was combined with NaOH in diff erent proportions (brain: 1 to 4, 
kidney and liver: 1 to 5 and heart: 1 to 10). Th en, 50% trichloroacetic acid (TCA) was 
added to the samples. Th e TCA solution (0.5 ml) was added to 2  g of brain or liver 
samples in tight 3 ml capsules, and 0.25 ml was added to 1 g of heart or kidney sample 
in tight 2 ml capsules. Th ese suspensions were shaken, and the resultant mixture was 
centrifuged. Subsequently, 1.5 ml brain or liver and 0.75 ml heart or kidney supernatant 
samples were moved to 2 ml tight capsules with 0.15 ml or 0.075 ml of 0.02 M N,N-
dimethyl-p-phenylenediamine sulfate in 7.2 M hydrochloric acid (HCl), and 0.15 ml 
or 0.075 ml of 0.03 M iron (III) chloride (FeCl3), respectively, was then added in 1.2 M 
HCl portions. Aft er 20 min in the dark, the contents were shaken for 1 min with 1 ml of 
chloroform. 
H2S tissue concentration measurements
Th e absorbance was measured at 650 nm with a Varian Cary 100 spectrophotometer. 
A standard curve was prepared with an iodometrically determined 0.0001 M sodium 
sulfi de (Na2S) solution. Four concurrent analyses of every analyzed tissue type were 
performed for each group of animals.
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Statistical analysis
Th e statistical analysis was performed with the Statistica 10 PL version (Statsoft , Tulsa, 
USA). Normal distribution of variables was disproved using the Shapiro-Wilk test. 
Subsequently, the existence of diff erences in H2S tissue concentrations among groups 
within one organ were assessed with Kruskal–Wallis one-way analysis of variance. 
Th e Mann-Whitney U test was used in the post hoc analysis for comparisons between 
selected pairs of groups (control group vs D1 group and control group vs D2 group). 
Statistical signifi cance was considered when p <0.05.
Results 
Th ere was a  signifi cant increase in H2S concentrations in both nicotine doses groups 
in the kidney (D1 by 54.2%, D2 by 40.0%). In the heart the higher nicotine dose 
caused a  marked decrease in H2S tissue level (by 65.4%), whereas the lower one did 
not aff ect H2S content (control group vs D2 group: 8.45 ± 0.07 μg/g vs 8.15 ± 0.13 
μg/g, p = 0.1143). Nicotine administration had no eff ect on H2S concentrations in the 
brain and liver. H2S tissue levels’ results are presented in the Table 1.
Table 1. Hydrogen sulfi de (H2S) tissue concentration in mouse brain, heart, liver and kidney following 
the administration of 1.5 mg/kg b.w. per day or 3 mg/kg b.w. per day of nicotine (groups D1 and D2, 
respectively). 
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Brain 1.70 ± 0.06 1.74 ± 0.03 1.81 ± 0.07 NS NS NS
Heart 8.45 ± 0.07 8.15 ± 0.13 2.92 ± 0.12 H(2, 12) = 8.80
p = 0.0123
NS p = 0.0294
Liver 2.43 ± 0.06 2.73 ± 0.10 2.46 ± 0.08 NS NS NS
Kidney 4.48 ± 0.17 6.91 ± 0.21 6.27 ± 0.16 H(2, 12) = 9.85
p = 0.0073
p = 0.0286 p = 0.0303
NS — statistically not signifi cant
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Discussion
In our experiment nicotine administration caused H2S tissue content elevation in 
the kidneys. Nicotine has worsened kidney function in diff erent studies on animal 
and human acute and chronic renal failure. Th e alkaloid was shown to be a powerful 
stimulus for human mesangial cell proliferation and fibronectin production. 
Th ese eff ects were accompanied by the increased activity of nicotinamide adenine 
dinucleotide phosphate-oxidase (NADPH) oxidase, leading to ROS and nitrotyrosine 
production, mitogen-activated protein kinases (MAPKs) activation, and were 
prevented by protein kinase C (PKC) inhibition [2, 22, 23]. Glomerular injury induced 
by nicotine was also shown to be mediated by augmented cyclooxygenase-2 (COX-2) 
expression and activity what was partially triggered by ROS [24]. Interestingly, 
NADPH oxidase, MAPKs, PKC are COX-2 are among molecular targets of H2S and 
H2S exerts a  broad array of protective actions in kidney failure conditions [10, 25]. 
H2S was demonstrated to inhibit nicotine and lipopolysaccharide-induced osteoclastic 
diff erentiation by blocking the activation of MAPKs, phosphoinositide 3-kinase (PI3K), 
PKC and nuclear factor-κB (NF-κB) [26]. Plasma concentration of H2S correlated 
negatively with the levels of conventional PKC βII activation and cardiovascular 
mortality index in chronic hemodialysis patients [27]. H2S administration in uranium-
intoxicated rats inhibited uranium-induced nuclear translocation and phosphorylation 
of NF-κB-p65, which decreased protein expression of target-p65 infl ammatory genes 
of TNF-α, inducible nitric oxide synthase (iNOS) and COX-2 [28]. H2S quenched 
angiotensin II-induced NADPH expression in cardiac fi broblasts what was associated 
with decreased ROS production, reduced MAPKs (Erk 1/2) phosphorylation and 
connective tissue growth factor (CTGF) expression [29].
In contrast, there are studies demonstrating anti-infl ammatory eff ects of nicotine 
occurring under specifi c circumstances. Single injections of the alkaloid attenuated 
the severity of renal injury in rat models of ischemia-reperfusion and in a model of 
sepsis which was associated with reductions in infl ammatory cytokines and NF-κB, 
what is observed among numerous biological actions of H2S [30–32]. Additionally, 
long-term administration of nicotine in the drinking water resulted in improvements 
in proteinuria and renal function in a  rat model of proteinuria-induced renal 
inflammation with unclear mechanisms [33]. These protective effects of nicotine 
might be partially mediated by H2S. 
As we have shown, nicotine caused decrease in H2S levels in the heart. Nicotine 
was proven to dysregulate sympathovagal balance in the heart, aff ecting heart rate, 
blood pressure, myocardial contractility, increasing myocardial demand for oxygen 
and nutrients, causing vasoconstriction and promoting tissue remodeling and fi brosis 
[3, 34]. In the study by JI and colleagues nicotine administration to isolated perfused 
rat hearts caused a  brief decrease followed by a  much larger increase in the heart 
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rate  [35]. Th e eff ects were attributed by the authors to diff erent nAChRs subtypes 
share but interactions with mediators in autonomic nervous system including H2S 
should strongly be considered. H2S was shown to modulate fast cholinergic synaptic 
input acting on presynaptic terminals in peripheral ganglia and neuromuscular 
junction activity what involved presynaptic ryanodine receptor [36, 37]. Furthermore, 
H2S was considered as an endothelium-derived hyperpolarizing factor mediated by 
Ach in rat cerebral vessels [38].
It should be emphasized that nicotine is only one of more than 9000 compounds 
found in cigarette smoke. Th is smoke contains many oxidizing chemicals, CO, volatile 
organic compounds, particulates, heavy metals, all with more than 60 identified 
carcinogens [39, 40]. Th e eff ects of nicotine are accompanied by many other actions 
of cigarette smoke contents. 
Growing evidence has revealed that H2S improves heart function and reduces 
cardiac complications in diff erent pathogenic conditions. H2S exerts antioxidative 
actions, preserves mitochondrial function, has anti-infl ammatory and antiapoptotic 
properties, angiogenic eff ects on the ischemic area, participates in the regulation of 
ion channels and microRNAs (miRNAs) expression, and interferes with NO and 
CO [41]. Th us, our fi ndings of nicotine reducing H2S content in the heart stresses 
the need for new directions of study on possible exogenous H2S supplementation in 
smoking and nicotine replacement therapy. 
We have not observed any effect of nicotine administration on H2S tissue 
levels in the brain and liver. In tobacco smoking the addictive nature of nicotine 
involves psychoactive effects, drug-reinforced behavior, compulsive use, relapse 
aft er abstinence, physical dependence and tolerance [42]. Th ese complex actions are 
mediated by close interactions of the glutamatergic, dopaminergic and γ-aminobutyric 
acidergic systems mainly in the mesocorticolimbic system [5]. H2S is perceived as 
a potent neuroprotector and neuromodulator [9]. 
In the liver nicotine evoked organ damage inducing oxidative stress, biochemical 
changes and histopathological injuries [43–45]. To the contrary, H2S displayed 
a crucial role in physiology and protective actions in liver pathology [46].
In conclusion, the influence of nicotine on H2S tissue concentrations in the 
kidney and heart tissues proves that the biological actions of nicotine involve impact 
on sulfur metabolism of undetermined mechanisms. Interestingly, the interactions 
between H2S and nicotine seem to begin long before nicotine is inhaled with cigarette 
smoke or administered as replacement therapy in smoking cessation: H2S has been 
recently identified as a  crucial modulator of nicotine biosynthesis in Nicotiana 
tabacum [47]. Our results are highly indicative but less conclusive. Th ey open new 
fi elds of research for the use of H2S donors and HS-releasing agents in the prevention 
of the complications of smoking and nicotine replacement therapy. Neither have we 
examined the infl uence of long-term exposure to nicotine, nor the eff ects of other 
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cigarette smoke constituents, what poses our experiment’s limitations. No effect 
of nicotine on H2S levels in the liver and brain absolutely does not preclude their 
interactions, especially in chronic exposure to nicotine. 
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